1Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a Randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 fads + 5-fluorouracil), and high dose radiation + 5- fluorouracil: The Gastrointestinal Tumor Study Group[J]. J Cancer, 1981,48: 1 705-1 710
2Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy(chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group[J]. J Natl Cancer Inst, 1988,80: 751 -755
3Burris H, Moore M, Andersen J, et al. improvement in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreas cancer: a randomized trial[J].J Clin Oncol,1997,15:2 403-2 413
4Latz D,Fleckenstein K, Eble M, et al. Radiosensizing potential of gemcitabin within the cell cycle in vitro[J]. J Int Radiat Oncol Biol Phys, 1998,41 : 875-882
5Ikeda M, Okada S, Tokuuye K, et al. A phase I trial of weekly gemcitablne and concurrent radiotherapy in patients with locallyadvanced pancreatic cancer[J]. Br J Cancer,2092,86:1 551-1 554
6Wilkowski R, Thoma M, Schauer R, et al. Effect of chemoradiotherapy with gemcitabine and cisplatin on Ioeoregional control in patients with primary inoperable panereatic cancer[J]. World J Surg,2004,28:1 011-1 018
7Sakmato H, Kitano M,Suetomi Y, et al. Comparison of standard-dose and low-dose gemeitabine regiments in pancreatic adenocarcinoma patients: a prospective randomized trial[J]. J Gastroenterol, 2006,41 : 70-76
8McGinn CJ, Zalupski MM, Shureiqii, et al. Phase I trial of ra diat ion dose escalation with concurrent weekly full dose gemcitabine in patients with advanced pancreatic cancer[J]. J Clin On col, 2001,19:4 202
9Wilkowski R, Thoma M, Bruns C, et al. Chemoradiotherapy with gemcitabine and continuous 5-fu in patients with primary inoperable pancreatic cancer[J]. JOP, 2006,7(4) : 349- 360
10Mancuso A,Calabro F,Sternberg CN. Current therapies and ad-vances in the treatment of pancreatic cancer[ J]. Crit Rev OncolHemat,2006,58(3) :231 -241.
